Replimune Group Inc (REPL)
12.48
-0.07
(-0.56%)
USD |
NASDAQ |
Dec 16, 16:00
12.50
+0.02
(+0.12%)
After-Hours: 20:00
Replimune Group Market Cap: 853.85M for Dec. 16, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Pfizer Inc | 143.09B |
Bristol-Myers Squibb Co | 113.31B |
Nuvalent Inc | 6.211B |
NovaBay Pharmaceuticals Inc | 2.773M |
Palatin Technologies Inc | 16.24M |
Market Cap Related Metrics
Price to Book Value | 2.238 |
Price | 12.48 |
Earnings Yield | -24.44% |